Global Peripheral Parenteral Nutrition (PPN) Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Peripheral Parenteral Nutrition (PPN) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Peripheral Parenteral Nutrition (PPN) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital accounting for % of the Peripheral Parenteral Nutrition (PPN) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Carbohydrates segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Peripheral Parenteral Nutrition (PPN) include Eurofarma, Corporacion De Laboratorios Farmaceuticos, Baxter International Inc., Kelun Pharma, and B. Braun, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Peripheral Parenteral Nutrition (PPN) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Peripheral Parenteral Nutrition (PPN) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Peripheral Parenteral Nutrition (PPN), with revenue, gross margin and global market share of Peripheral Parenteral Nutrition (PPN) from 2019 to 2022.
Chapter 3, the Peripheral Parenteral Nutrition (PPN) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Peripheral Parenteral Nutrition (PPN) market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Peripheral Parenteral Nutrition (PPN) research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Peripheral Parenteral Nutrition (PPN) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital accounting for % of the Peripheral Parenteral Nutrition (PPN) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Carbohydrates segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Peripheral Parenteral Nutrition (PPN) include Eurofarma, Corporacion De Laboratorios Farmaceuticos, Baxter International Inc., Kelun Pharma, and B. Braun, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Peripheral Parenteral Nutrition (PPN) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Carbohydrates
- Parenteral Lipid Emulsion
- Single Dose Amino Acid Solution
- Trace Elements
- Vitamins and Minerals
- Hospital
- Home
- Eurofarma
- Corporacion De Laboratorios Farmaceuticos
- Baxter International Inc.
- Kelun Pharma
- B. Braun
- Fresenius
- Teva Pharmaceutical Industries
- Pfizer (Hospira)
- Ostuka Pharmaceutical
- Laboratorios Biogalenic
- Laboratorios Finlay
- Grifols International
- Fresenius Kabi
- Sichuan Kelun Pharmaceutical
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Peripheral Parenteral Nutrition (PPN) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Peripheral Parenteral Nutrition (PPN), with revenue, gross margin and global market share of Peripheral Parenteral Nutrition (PPN) from 2019 to 2022.
Chapter 3, the Peripheral Parenteral Nutrition (PPN) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Peripheral Parenteral Nutrition (PPN) market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Peripheral Parenteral Nutrition (PPN) research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Peripheral Parenteral Nutrition (PPN)
1.2 Classification of Peripheral Parenteral Nutrition (PPN) by Type
1.2.1 Overview: Global Peripheral Parenteral Nutrition (PPN) Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Type in 2021
1.2.3 Carbohydrates
1.2.4 Parenteral Lipid Emulsion
1.2.5 Single Dose Amino Acid Solution
1.2.6 Trace Elements
1.2.7 Vitamins and Minerals
1.3 Global Peripheral Parenteral Nutrition (PPN) Market by Application
1.3.1 Overview: Global Peripheral Parenteral Nutrition (PPN) Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Home
1.4 Global Peripheral Parenteral Nutrition (PPN) Market Size & Forecast
1.5 Global Peripheral Parenteral Nutrition (PPN) Market Size and Forecast by Region
1.5.1 Global Peripheral Parenteral Nutrition (PPN) Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Peripheral Parenteral Nutrition (PPN) Market Size by Region, (2017-2022)
1.5.3 North America Peripheral Parenteral Nutrition (PPN) Market Size and Prospect (2017-2028)
1.5.4 Europe Peripheral Parenteral Nutrition (PPN) Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size and Prospect (2017-2028)
1.5.6 South America Peripheral Parenteral Nutrition (PPN) Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Peripheral Parenteral Nutrition (PPN) Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Peripheral Parenteral Nutrition (PPN) Market Drivers
1.6.2 Peripheral Parenteral Nutrition (PPN) Market Restraints
1.6.3 Peripheral Parenteral Nutrition (PPN) Trends Analysis
2 COMPANY PROFILES
2.1 Eurofarma
2.1.1 Eurofarma Details
2.1.2 Eurofarma Major Business
2.1.3 Eurofarma Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.1.4 Eurofarma Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Eurofarma Recent Developments and Future Plans
2.2 Corporacion De Laboratorios Farmaceuticos
2.2.1 Corporacion De Laboratorios Farmaceuticos Details
2.2.2 Corporacion De Laboratorios Farmaceuticos Major Business
2.2.3 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.2.4 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Corporacion De Laboratorios Farmaceuticos Recent Developments and Future Plans
2.3 Baxter International Inc.
2.3.1 Baxter International Inc. Details
2.3.2 Baxter International Inc. Major Business
2.3.3 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.3.4 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Baxter International Inc. Recent Developments and Future Plans
2.4 Kelun Pharma
2.4.1 Kelun Pharma Details
2.4.2 Kelun Pharma Major Business
2.4.3 Kelun Pharma Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.4.4 Kelun Pharma Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Kelun Pharma Recent Developments and Future Plans
2.5 B. Braun
2.5.1 B. Braun Details
2.5.2 B. Braun Major Business
2.5.3 B. Braun Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.5.4 B. Braun Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 B. Braun Recent Developments and Future Plans
2.6 Fresenius
2.6.1 Fresenius Details
2.6.2 Fresenius Major Business
2.6.3 Fresenius Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.6.4 Fresenius Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Fresenius Recent Developments and Future Plans
2.7 Teva Pharmaceutical Industries
2.7.1 Teva Pharmaceutical Industries Details
2.7.2 Teva Pharmaceutical Industries Major Business
2.7.3 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.7.4 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Teva Pharmaceutical Industries Recent Developments and Future Plans
2.8 Pfizer (Hospira)
2.8.1 Pfizer (Hospira) Details
2.8.2 Pfizer (Hospira) Major Business
2.8.3 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.8.4 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Pfizer (Hospira) Recent Developments and Future Plans
2.9 Ostuka Pharmaceutical
2.9.1 Ostuka Pharmaceutical Details
2.9.2 Ostuka Pharmaceutical Major Business
2.9.3 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.9.4 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Ostuka Pharmaceutical Recent Developments and Future Plans
2.10 Laboratorios Biogalenic
2.10.1 Laboratorios Biogalenic Details
2.10.2 Laboratorios Biogalenic Major Business
2.10.3 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.10.4 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Laboratorios Biogalenic Recent Developments and Future Plans
2.11 Laboratorios Finlay
2.11.1 Laboratorios Finlay Details
2.11.2 Laboratorios Finlay Major Business
2.11.3 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.11.4 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Laboratorios Finlay Recent Developments and Future Plans
2.12 Grifols International
2.12.1 Grifols International Details
2.12.2 Grifols International Major Business
2.12.3 Grifols International Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.12.4 Grifols International Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Grifols International Recent Developments and Future Plans
2.13 Fresenius Kabi
2.13.1 Fresenius Kabi Details
2.13.2 Fresenius Kabi Major Business
2.13.3 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.13.4 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Fresenius Kabi Recent Developments and Future Plans
2.14 Sichuan Kelun Pharmaceutical
2.14.1 Sichuan Kelun Pharmaceutical Details
2.14.2 Sichuan Kelun Pharmaceutical Major Business
2.14.3 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.14.4 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Sichuan Kelun Pharmaceutical Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Peripheral Parenteral Nutrition (PPN) Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Peripheral Parenteral Nutrition (PPN) Players Market Share in 2021
3.2.2 Top 10 Peripheral Parenteral Nutrition (PPN) Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Peripheral Parenteral Nutrition (PPN) Players Head Office, Products and Services Provided
3.4 Peripheral Parenteral Nutrition (PPN) Mergers & Acquisitions
3.5 Peripheral Parenteral Nutrition (PPN) New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Peripheral Parenteral Nutrition (PPN) Revenue and Market Share by Type (2017-2022)
4.2 Global Peripheral Parenteral Nutrition (PPN) Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Application (2017-2022)
5.2 Global Peripheral Parenteral Nutrition (PPN) Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Peripheral Parenteral Nutrition (PPN) Revenue by Type (2017-2028)
6.2 North America Peripheral Parenteral Nutrition (PPN) Revenue by Application (2017-2028)
6.3 North America Peripheral Parenteral Nutrition (PPN) Market Size by Country
6.3.1 North America Peripheral Parenteral Nutrition (PPN) Revenue by Country (2017-2028)
6.3.2 United States Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
6.3.3 Canada Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
6.3.4 Mexico Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Peripheral Parenteral Nutrition (PPN) Revenue by Type (2017-2028)
7.2 Europe Peripheral Parenteral Nutrition (PPN) Revenue by Application (2017-2028)
7.3 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country
7.3.1 Europe Peripheral Parenteral Nutrition (PPN) Revenue by Country (2017-2028)
7.3.2 Germany Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
7.3.3 France Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
7.3.5 Russia Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
7.3.6 Italy Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Revenue by Type (2017-2028)
8.2 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Revenue by Application (2017-2028)
8.3 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Region
8.3.1 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Revenue by Region (2017-2028)
8.3.2 China Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
8.3.3 Japan Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
8.3.4 South Korea Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
8.3.5 India Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
8.3.7 Australia Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Peripheral Parenteral Nutrition (PPN) Revenue by Type (2017-2028)
9.2 South America Peripheral Parenteral Nutrition (PPN) Revenue by Application (2017-2028)
9.3 South America Peripheral Parenteral Nutrition (PPN) Market Size by Country
9.3.1 South America Peripheral Parenteral Nutrition (PPN) Revenue by Country (2017-2028)
9.3.2 Brazil Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
9.3.3 Argentina Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Revenue by Type (2017-2028)
10.2 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Revenue by Application (2017-2028)
10.3 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country
10.3.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Revenue by Country (2017-2028)
10.3.2 Turkey Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
10.3.4 UAE Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Peripheral Parenteral Nutrition (PPN)
1.2 Classification of Peripheral Parenteral Nutrition (PPN) by Type
1.2.1 Overview: Global Peripheral Parenteral Nutrition (PPN) Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Type in 2021
1.2.3 Carbohydrates
1.2.4 Parenteral Lipid Emulsion
1.2.5 Single Dose Amino Acid Solution
1.2.6 Trace Elements
1.2.7 Vitamins and Minerals
1.3 Global Peripheral Parenteral Nutrition (PPN) Market by Application
1.3.1 Overview: Global Peripheral Parenteral Nutrition (PPN) Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Home
1.4 Global Peripheral Parenteral Nutrition (PPN) Market Size & Forecast
1.5 Global Peripheral Parenteral Nutrition (PPN) Market Size and Forecast by Region
1.5.1 Global Peripheral Parenteral Nutrition (PPN) Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Peripheral Parenteral Nutrition (PPN) Market Size by Region, (2017-2022)
1.5.3 North America Peripheral Parenteral Nutrition (PPN) Market Size and Prospect (2017-2028)
1.5.4 Europe Peripheral Parenteral Nutrition (PPN) Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size and Prospect (2017-2028)
1.5.6 South America Peripheral Parenteral Nutrition (PPN) Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Peripheral Parenteral Nutrition (PPN) Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Peripheral Parenteral Nutrition (PPN) Market Drivers
1.6.2 Peripheral Parenteral Nutrition (PPN) Market Restraints
1.6.3 Peripheral Parenteral Nutrition (PPN) Trends Analysis
2 COMPANY PROFILES
2.1 Eurofarma
2.1.1 Eurofarma Details
2.1.2 Eurofarma Major Business
2.1.3 Eurofarma Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.1.4 Eurofarma Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Eurofarma Recent Developments and Future Plans
2.2 Corporacion De Laboratorios Farmaceuticos
2.2.1 Corporacion De Laboratorios Farmaceuticos Details
2.2.2 Corporacion De Laboratorios Farmaceuticos Major Business
2.2.3 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.2.4 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Corporacion De Laboratorios Farmaceuticos Recent Developments and Future Plans
2.3 Baxter International Inc.
2.3.1 Baxter International Inc. Details
2.3.2 Baxter International Inc. Major Business
2.3.3 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.3.4 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Baxter International Inc. Recent Developments and Future Plans
2.4 Kelun Pharma
2.4.1 Kelun Pharma Details
2.4.2 Kelun Pharma Major Business
2.4.3 Kelun Pharma Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.4.4 Kelun Pharma Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Kelun Pharma Recent Developments and Future Plans
2.5 B. Braun
2.5.1 B. Braun Details
2.5.2 B. Braun Major Business
2.5.3 B. Braun Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.5.4 B. Braun Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 B. Braun Recent Developments and Future Plans
2.6 Fresenius
2.6.1 Fresenius Details
2.6.2 Fresenius Major Business
2.6.3 Fresenius Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.6.4 Fresenius Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Fresenius Recent Developments and Future Plans
2.7 Teva Pharmaceutical Industries
2.7.1 Teva Pharmaceutical Industries Details
2.7.2 Teva Pharmaceutical Industries Major Business
2.7.3 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.7.4 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Teva Pharmaceutical Industries Recent Developments and Future Plans
2.8 Pfizer (Hospira)
2.8.1 Pfizer (Hospira) Details
2.8.2 Pfizer (Hospira) Major Business
2.8.3 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.8.4 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Pfizer (Hospira) Recent Developments and Future Plans
2.9 Ostuka Pharmaceutical
2.9.1 Ostuka Pharmaceutical Details
2.9.2 Ostuka Pharmaceutical Major Business
2.9.3 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.9.4 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Ostuka Pharmaceutical Recent Developments and Future Plans
2.10 Laboratorios Biogalenic
2.10.1 Laboratorios Biogalenic Details
2.10.2 Laboratorios Biogalenic Major Business
2.10.3 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.10.4 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Laboratorios Biogalenic Recent Developments and Future Plans
2.11 Laboratorios Finlay
2.11.1 Laboratorios Finlay Details
2.11.2 Laboratorios Finlay Major Business
2.11.3 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.11.4 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Laboratorios Finlay Recent Developments and Future Plans
2.12 Grifols International
2.12.1 Grifols International Details
2.12.2 Grifols International Major Business
2.12.3 Grifols International Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.12.4 Grifols International Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Grifols International Recent Developments and Future Plans
2.13 Fresenius Kabi
2.13.1 Fresenius Kabi Details
2.13.2 Fresenius Kabi Major Business
2.13.3 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.13.4 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Fresenius Kabi Recent Developments and Future Plans
2.14 Sichuan Kelun Pharmaceutical
2.14.1 Sichuan Kelun Pharmaceutical Details
2.14.2 Sichuan Kelun Pharmaceutical Major Business
2.14.3 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product and Solutions
2.14.4 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Sichuan Kelun Pharmaceutical Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Peripheral Parenteral Nutrition (PPN) Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Peripheral Parenteral Nutrition (PPN) Players Market Share in 2021
3.2.2 Top 10 Peripheral Parenteral Nutrition (PPN) Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Peripheral Parenteral Nutrition (PPN) Players Head Office, Products and Services Provided
3.4 Peripheral Parenteral Nutrition (PPN) Mergers & Acquisitions
3.5 Peripheral Parenteral Nutrition (PPN) New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Peripheral Parenteral Nutrition (PPN) Revenue and Market Share by Type (2017-2022)
4.2 Global Peripheral Parenteral Nutrition (PPN) Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Application (2017-2022)
5.2 Global Peripheral Parenteral Nutrition (PPN) Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Peripheral Parenteral Nutrition (PPN) Revenue by Type (2017-2028)
6.2 North America Peripheral Parenteral Nutrition (PPN) Revenue by Application (2017-2028)
6.3 North America Peripheral Parenteral Nutrition (PPN) Market Size by Country
6.3.1 North America Peripheral Parenteral Nutrition (PPN) Revenue by Country (2017-2028)
6.3.2 United States Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
6.3.3 Canada Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
6.3.4 Mexico Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Peripheral Parenteral Nutrition (PPN) Revenue by Type (2017-2028)
7.2 Europe Peripheral Parenteral Nutrition (PPN) Revenue by Application (2017-2028)
7.3 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country
7.3.1 Europe Peripheral Parenteral Nutrition (PPN) Revenue by Country (2017-2028)
7.3.2 Germany Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
7.3.3 France Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
7.3.5 Russia Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
7.3.6 Italy Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Revenue by Type (2017-2028)
8.2 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Revenue by Application (2017-2028)
8.3 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Region
8.3.1 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Revenue by Region (2017-2028)
8.3.2 China Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
8.3.3 Japan Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
8.3.4 South Korea Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
8.3.5 India Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
8.3.7 Australia Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Peripheral Parenteral Nutrition (PPN) Revenue by Type (2017-2028)
9.2 South America Peripheral Parenteral Nutrition (PPN) Revenue by Application (2017-2028)
9.3 South America Peripheral Parenteral Nutrition (PPN) Market Size by Country
9.3.1 South America Peripheral Parenteral Nutrition (PPN) Revenue by Country (2017-2028)
9.3.2 Brazil Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
9.3.3 Argentina Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Revenue by Type (2017-2028)
10.2 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Revenue by Application (2017-2028)
10.3 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country
10.3.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Revenue by Country (2017-2028)
10.3.2 Turkey Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
10.3.4 UAE Peripheral Parenteral Nutrition (PPN) Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. Global Peripheral Parenteral Nutrition (PPN) Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Peripheral Parenteral Nutrition (PPN) Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Peripheral Parenteral Nutrition (PPN) Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Peripheral Parenteral Nutrition (PPN) Revenue (USD Million) by Region (2017-2022)
Table 5. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Region (2023-2028)
Table 6. Eurofarma Corporate Information, Head Office, and Major Competitors
Table 7. Eurofarma Major Business
Table 8. Eurofarma Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 9. Eurofarma Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Corporacion De Laboratorios Farmaceuticos Corporate Information, Head Office, and Major Competitors
Table 11. Corporacion De Laboratorios Farmaceuticos Major Business
Table 12. Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 13. Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Baxter International Inc. Corporate Information, Head Office, and Major Competitors
Table 15. Baxter International Inc. Major Business
Table 16. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 17. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Kelun Pharma Corporate Information, Head Office, and Major Competitors
Table 19. Kelun Pharma Major Business
Table 20. Kelun Pharma Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 21. Kelun Pharma Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. B. Braun Corporate Information, Head Office, and Major Competitors
Table 23. B. Braun Major Business
Table 24. B. Braun Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 25. B. Braun Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Fresenius Corporate Information, Head Office, and Major Competitors
Table 27. Fresenius Major Business
Table 28. Fresenius Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 29. Fresenius Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Teva Pharmaceutical Industries Corporate Information, Head Office, and Major Competitors
Table 31. Teva Pharmaceutical Industries Major Business
Table 32. Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 33. Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Pfizer (Hospira) Corporate Information, Head Office, and Major Competitors
Table 35. Pfizer (Hospira) Major Business
Table 36. Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 37. Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Ostuka Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 39. Ostuka Pharmaceutical Major Business
Table 40. Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 41. Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Laboratorios Biogalenic Corporate Information, Head Office, and Major Competitors
Table 43. Laboratorios Biogalenic Major Business
Table 44. Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 45. Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Laboratorios Finlay Corporate Information, Head Office, and Major Competitors
Table 47. Laboratorios Finlay Major Business
Table 48. Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 49. Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Grifols International Corporate Information, Head Office, and Major Competitors
Table 51. Grifols International Major Business
Table 52. Grifols International Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 53. Grifols International Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Fresenius Kabi Corporate Information, Head Office, and Major Competitors
Table 55. Fresenius Kabi Major Business
Table 56. Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 57. Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Sichuan Kelun Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 59. Sichuan Kelun Pharmaceutical Major Business
Table 60. Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 61. Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Global Peripheral Parenteral Nutrition (PPN) Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 63. Global Peripheral Parenteral Nutrition (PPN) Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 64. Breakdown of Peripheral Parenteral Nutrition (PPN) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Peripheral Parenteral Nutrition (PPN) Players Head Office, Products and Services Provided
Table 66. Peripheral Parenteral Nutrition (PPN) Mergers & Acquisitions in the Past Five Years
Table 67. Peripheral Parenteral Nutrition (PPN) New Entrants and Expansion Plans
Table 68. Global Peripheral Parenteral Nutrition (PPN) Revenue (USD Million) by Type (2017-2022)
Table 69. Global Peripheral Parenteral Nutrition (PPN) Revenue Share by Type (2017-2022)
Table 70. Global Peripheral Parenteral Nutrition (PPN) Revenue Forecast by Type (2023-2028)
Table 71. Global Peripheral Parenteral Nutrition (PPN) Revenue by Application (2017-2022)
Table 72. Global Peripheral Parenteral Nutrition (PPN) Revenue Forecast by Application (2023-2028)
Table 73. North America Peripheral Parenteral Nutrition (PPN) Revenue by Type (2017-2022) & (USD Million)
Table 74. North America Peripheral Parenteral Nutrition (PPN) Revenue by Type (2023-2028) & (USD Million)
Table 75. North America Peripheral Parenteral Nutrition (PPN) Revenue by Application (2017-2022) & (USD Million)
Table 76. North America Peripheral Parenteral Nutrition (PPN) Revenue by Application (2023-2028) & (USD Million)
Table 77. North America Peripheral Parenteral Nutrition (PPN) Revenue by Country (2017-2022) & (USD Million)
Table 78. North America Peripheral Parenteral Nutrition (PPN) Revenue by Country (2023-2028) & (USD Million)
Table 79. Europe Peripheral Parenteral Nutrition (PPN) Revenue by Type (2017-2022) & (USD Million)
Table 80. Europe Peripheral Parenteral Nutrition (PPN) Revenue by Type (2023-2028) & (USD Million)
Table 81. Europe Peripheral Parenteral Nutrition (PPN) Revenue by Application (2017-2022) & (USD Million)
Table 82. Europe Peripheral Parenteral Nutrition (PPN) Revenue by Application (2023-2028) & (USD Million)
Table 83. Europe Peripheral Parenteral Nutrition (PPN) Revenue by Country (2017-2022) & (USD Million)
Table 84. Europe Peripheral Parenteral Nutrition (PPN) Revenue by Country (2023-2028) & (USD Million)
Table 85. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Revenue by Type (2017-2022) & (USD Million)
Table 86. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Revenue by Type (2023-2028) & (USD Million)
Table 87. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Revenue by Application (2017-2022) & (USD Million)
Table 88. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Revenue by Application (2023-2028) & (USD Million)
Table 89. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Revenue by Region (2017-2022) & (USD Million)
Table 90. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Revenue by Region (2023-2028) & (USD Million)
Table 91. South America Peripheral Parenteral Nutrition (PPN) Revenue by Type (2017-2022) & (USD Million)
Table 92. South America Peripheral Parenteral Nutrition (PPN) Revenue by Type (2023-2028) & (USD Million)
Table 93. South America Peripheral Parenteral Nutrition (PPN) Revenue by Application (2017-2022) & (USD Million)
Table 94. South America Peripheral Parenteral Nutrition (PPN) Revenue by Application (2023-2028) & (USD Million)
Table 95. South America Peripheral Parenteral Nutrition (PPN) Revenue by Country (2017-2022) & (USD Million)
Table 96. South America Peripheral Parenteral Nutrition (PPN) Revenue by Country (2023-2028) & (USD Million)
Table 97. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Revenue by Type (2017-2022) & (USD Million)
Table 98. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Revenue by Type (2023-2028) & (USD Million)
Table 99. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Revenue by Application (2017-2022) & (USD Million)
Table 100. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Revenue by Application (2023-2028) & (USD Million)
Table 101. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Revenue by Country (2017-2022) & (USD Million)
Table 102. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Revenue by Country (2023-2028) & (USD Million)
Table 1. Global Peripheral Parenteral Nutrition (PPN) Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Peripheral Parenteral Nutrition (PPN) Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Peripheral Parenteral Nutrition (PPN) Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Peripheral Parenteral Nutrition (PPN) Revenue (USD Million) by Region (2017-2022)
Table 5. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Region (2023-2028)
Table 6. Eurofarma Corporate Information, Head Office, and Major Competitors
Table 7. Eurofarma Major Business
Table 8. Eurofarma Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 9. Eurofarma Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Corporacion De Laboratorios Farmaceuticos Corporate Information, Head Office, and Major Competitors
Table 11. Corporacion De Laboratorios Farmaceuticos Major Business
Table 12. Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 13. Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Baxter International Inc. Corporate Information, Head Office, and Major Competitors
Table 15. Baxter International Inc. Major Business
Table 16. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 17. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Kelun Pharma Corporate Information, Head Office, and Major Competitors
Table 19. Kelun Pharma Major Business
Table 20. Kelun Pharma Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 21. Kelun Pharma Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. B. Braun Corporate Information, Head Office, and Major Competitors
Table 23. B. Braun Major Business
Table 24. B. Braun Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 25. B. Braun Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Fresenius Corporate Information, Head Office, and Major Competitors
Table 27. Fresenius Major Business
Table 28. Fresenius Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 29. Fresenius Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Teva Pharmaceutical Industries Corporate Information, Head Office, and Major Competitors
Table 31. Teva Pharmaceutical Industries Major Business
Table 32. Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 33. Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Pfizer (Hospira) Corporate Information, Head Office, and Major Competitors
Table 35. Pfizer (Hospira) Major Business
Table 36. Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 37. Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Ostuka Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 39. Ostuka Pharmaceutical Major Business
Table 40. Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 41. Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Laboratorios Biogalenic Corporate Information, Head Office, and Major Competitors
Table 43. Laboratorios Biogalenic Major Business
Table 44. Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 45. Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Laboratorios Finlay Corporate Information, Head Office, and Major Competitors
Table 47. Laboratorios Finlay Major Business
Table 48. Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 49. Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Grifols International Corporate Information, Head Office, and Major Competitors
Table 51. Grifols International Major Business
Table 52. Grifols International Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 53. Grifols International Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Fresenius Kabi Corporate Information, Head Office, and Major Competitors
Table 55. Fresenius Kabi Major Business
Table 56. Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 57. Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Sichuan Kelun Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 59. Sichuan Kelun Pharmaceutical Major Business
Table 60. Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product and Solutions
Table 61. Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Global Peripheral Parenteral Nutrition (PPN) Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 63. Global Peripheral Parenteral Nutrition (PPN) Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 64. Breakdown of Peripheral Parenteral Nutrition (PPN) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Peripheral Parenteral Nutrition (PPN) Players Head Office, Products and Services Provided
Table 66. Peripheral Parenteral Nutrition (PPN) Mergers & Acquisitions in the Past Five Years
Table 67. Peripheral Parenteral Nutrition (PPN) New Entrants and Expansion Plans
Table 68. Global Peripheral Parenteral Nutrition (PPN) Revenue (USD Million) by Type (2017-2022)
Table 69. Global Peripheral Parenteral Nutrition (PPN) Revenue Share by Type (2017-2022)
Table 70. Global Peripheral Parenteral Nutrition (PPN) Revenue Forecast by Type (2023-2028)
Table 71. Global Peripheral Parenteral Nutrition (PPN) Revenue by Application (2017-2022)
Table 72. Global Peripheral Parenteral Nutrition (PPN) Revenue Forecast by Application (2023-2028)
Table 73. North America Peripheral Parenteral Nutrition (PPN) Revenue by Type (2017-2022) & (USD Million)
Table 74. North America Peripheral Parenteral Nutrition (PPN) Revenue by Type (2023-2028) & (USD Million)
Table 75. North America Peripheral Parenteral Nutrition (PPN) Revenue by Application (2017-2022) & (USD Million)
Table 76. North America Peripheral Parenteral Nutrition (PPN) Revenue by Application (2023-2028) & (USD Million)
Table 77. North America Peripheral Parenteral Nutrition (PPN) Revenue by Country (2017-2022) & (USD Million)
Table 78. North America Peripheral Parenteral Nutrition (PPN) Revenue by Country (2023-2028) & (USD Million)
Table 79. Europe Peripheral Parenteral Nutrition (PPN) Revenue by Type (2017-2022) & (USD Million)
Table 80. Europe Peripheral Parenteral Nutrition (PPN) Revenue by Type (2023-2028) & (USD Million)
Table 81. Europe Peripheral Parenteral Nutrition (PPN) Revenue by Application (2017-2022) & (USD Million)
Table 82. Europe Peripheral Parenteral Nutrition (PPN) Revenue by Application (2023-2028) & (USD Million)
Table 83. Europe Peripheral Parenteral Nutrition (PPN) Revenue by Country (2017-2022) & (USD Million)
Table 84. Europe Peripheral Parenteral Nutrition (PPN) Revenue by Country (2023-2028) & (USD Million)
Table 85. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Revenue by Type (2017-2022) & (USD Million)
Table 86. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Revenue by Type (2023-2028) & (USD Million)
Table 87. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Revenue by Application (2017-2022) & (USD Million)
Table 88. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Revenue by Application (2023-2028) & (USD Million)
Table 89. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Revenue by Region (2017-2022) & (USD Million)
Table 90. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Revenue by Region (2023-2028) & (USD Million)
Table 91. South America Peripheral Parenteral Nutrition (PPN) Revenue by Type (2017-2022) & (USD Million)
Table 92. South America Peripheral Parenteral Nutrition (PPN) Revenue by Type (2023-2028) & (USD Million)
Table 93. South America Peripheral Parenteral Nutrition (PPN) Revenue by Application (2017-2022) & (USD Million)
Table 94. South America Peripheral Parenteral Nutrition (PPN) Revenue by Application (2023-2028) & (USD Million)
Table 95. South America Peripheral Parenteral Nutrition (PPN) Revenue by Country (2017-2022) & (USD Million)
Table 96. South America Peripheral Parenteral Nutrition (PPN) Revenue by Country (2023-2028) & (USD Million)
Table 97. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Revenue by Type (2017-2022) & (USD Million)
Table 98. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Revenue by Type (2023-2028) & (USD Million)
Table 99. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Revenue by Application (2017-2022) & (USD Million)
Table 100. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Revenue by Application (2023-2028) & (USD Million)
Table 101. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Revenue by Country (2017-2022) & (USD Million)
Table 102. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Revenue by Country (2023-2028) & (USD Million)
LIST OF FIGURES
Figure 1. Peripheral Parenteral Nutrition (PPN) Picture
Figure 2. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Type in 2021
Figure 3. Carbohydrates
Figure 4. Parenteral Lipid Emulsion
Figure 5. Single Dose Amino Acid Solution
Figure 6. Trace Elements
Figure 7. Vitamins and Minerals
Figure 8. Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Application in 2021
Figure 9. Hospital Picture
Figure 10. Home Picture
Figure 11. Global Peripheral Parenteral Nutrition (PPN) Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Peripheral Parenteral Nutrition (PPN) Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Region (2017-2028)
Figure 14. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Region in 2021
Figure 15. North America Peripheral Parenteral Nutrition (PPN) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Peripheral Parenteral Nutrition (PPN) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Peripheral Parenteral Nutrition (PPN) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Peripheral Parenteral Nutrition (PPN) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Peripheral Parenteral Nutrition (PPN) Market Drivers
Figure 21. Peripheral Parenteral Nutrition (PPN) Market Restraints
Figure 22. Peripheral Parenteral Nutrition (PPN) Market Trends
Figure 23. Eurofarma Recent Developments and Future Plans
Figure 24. Corporacion De Laboratorios Farmaceuticos Recent Developments and Future Plans
Figure 25. Baxter International Inc. Recent Developments and Future Plans
Figure 26. Kelun Pharma Recent Developments and Future Plans
Figure 27. B. Braun Recent Developments and Future Plans
Figure 28. Fresenius Recent Developments and Future Plans
Figure 29. Teva Pharmaceutical Industries Recent Developments and Future Plans
Figure 30. Pfizer (Hospira) Recent Developments and Future Plans
Figure 31. Ostuka Pharmaceutical Recent Developments and Future Plans
Figure 32. Laboratorios Biogalenic Recent Developments and Future Plans
Figure 33. Laboratorios Finlay Recent Developments and Future Plans
Figure 34. Grifols International Recent Developments and Future Plans
Figure 35. Fresenius Kabi Recent Developments and Future Plans
Figure 36. Sichuan Kelun Pharmaceutical Recent Developments and Future Plans
Figure 37. Global Peripheral Parenteral Nutrition (PPN) Revenue Share by Players in 2021
Figure 38. Peripheral Parenteral Nutrition (PPN) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 39. Global Top 3 Players Peripheral Parenteral Nutrition (PPN) Revenue Market Share in 2021
Figure 40. Global Top 10 Players Peripheral Parenteral Nutrition (PPN) Revenue Market Share in 2021
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 42. Global Peripheral Parenteral Nutrition (PPN) Revenue Share by Type in 2021
Figure 43. Global Peripheral Parenteral Nutrition (PPN) Market Share Forecast by Type (2023-2028)
Figure 44. Global Peripheral Parenteral Nutrition (PPN) Revenue Share by Application in 2021
Figure 45. Global Peripheral Parenteral Nutrition (PPN) Market Share Forecast by Application (2023-2028)
Figure 46. North America Peripheral Parenteral Nutrition (PPN) Sales Market Share by Type (2017-2028)
Figure 47. North America Peripheral Parenteral Nutrition (PPN) Sales Market Share by Application (2017-2028)
Figure 48. North America Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Country (2017-2028)
Figure 49. United States Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Canada Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Mexico Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Europe Peripheral Parenteral Nutrition (PPN) Sales Market Share by Type (2017-2028)
Figure 53. Europe Peripheral Parenteral Nutrition (PPN) Sales Market Share by Application (2017-2028)
Figure 54. Europe Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Country (2017-2028)
Figure 55. Germany Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. France Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. United Kingdom Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Russia Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Italy Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Sales Market Share by Type (2017-2028)
Figure 61. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Sales Market Share by Application (2017-2028)
Figure 62. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Region (2017-2028)
Figure 63. China Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South Korea Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Peripheral Parenteral Nutrition (PPN) Sales Market Share by Type (2017-2028)
Figure 70. South America Peripheral Parenteral Nutrition (PPN) Sales Market Share by Application (2017-2028)
Figure 71. South America Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East and Africa Peripheral Parenteral Nutrition (PPN) Sales Market Share by Type (2017-2028)
Figure 75. Middle East and Africa Peripheral Parenteral Nutrition (PPN) Sales Market Share by Application (2017-2028)
Figure 76. Middle East and Africa Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Country (2017-2028)
Figure 77. Turkey Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. UAE Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
Figure 1. Peripheral Parenteral Nutrition (PPN) Picture
Figure 2. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Type in 2021
Figure 3. Carbohydrates
Figure 4. Parenteral Lipid Emulsion
Figure 5. Single Dose Amino Acid Solution
Figure 6. Trace Elements
Figure 7. Vitamins and Minerals
Figure 8. Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Application in 2021
Figure 9. Hospital Picture
Figure 10. Home Picture
Figure 11. Global Peripheral Parenteral Nutrition (PPN) Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Peripheral Parenteral Nutrition (PPN) Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Region (2017-2028)
Figure 14. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Region in 2021
Figure 15. North America Peripheral Parenteral Nutrition (PPN) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Peripheral Parenteral Nutrition (PPN) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Peripheral Parenteral Nutrition (PPN) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Peripheral Parenteral Nutrition (PPN) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Peripheral Parenteral Nutrition (PPN) Market Drivers
Figure 21. Peripheral Parenteral Nutrition (PPN) Market Restraints
Figure 22. Peripheral Parenteral Nutrition (PPN) Market Trends
Figure 23. Eurofarma Recent Developments and Future Plans
Figure 24. Corporacion De Laboratorios Farmaceuticos Recent Developments and Future Plans
Figure 25. Baxter International Inc. Recent Developments and Future Plans
Figure 26. Kelun Pharma Recent Developments and Future Plans
Figure 27. B. Braun Recent Developments and Future Plans
Figure 28. Fresenius Recent Developments and Future Plans
Figure 29. Teva Pharmaceutical Industries Recent Developments and Future Plans
Figure 30. Pfizer (Hospira) Recent Developments and Future Plans
Figure 31. Ostuka Pharmaceutical Recent Developments and Future Plans
Figure 32. Laboratorios Biogalenic Recent Developments and Future Plans
Figure 33. Laboratorios Finlay Recent Developments and Future Plans
Figure 34. Grifols International Recent Developments and Future Plans
Figure 35. Fresenius Kabi Recent Developments and Future Plans
Figure 36. Sichuan Kelun Pharmaceutical Recent Developments and Future Plans
Figure 37. Global Peripheral Parenteral Nutrition (PPN) Revenue Share by Players in 2021
Figure 38. Peripheral Parenteral Nutrition (PPN) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 39. Global Top 3 Players Peripheral Parenteral Nutrition (PPN) Revenue Market Share in 2021
Figure 40. Global Top 10 Players Peripheral Parenteral Nutrition (PPN) Revenue Market Share in 2021
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 42. Global Peripheral Parenteral Nutrition (PPN) Revenue Share by Type in 2021
Figure 43. Global Peripheral Parenteral Nutrition (PPN) Market Share Forecast by Type (2023-2028)
Figure 44. Global Peripheral Parenteral Nutrition (PPN) Revenue Share by Application in 2021
Figure 45. Global Peripheral Parenteral Nutrition (PPN) Market Share Forecast by Application (2023-2028)
Figure 46. North America Peripheral Parenteral Nutrition (PPN) Sales Market Share by Type (2017-2028)
Figure 47. North America Peripheral Parenteral Nutrition (PPN) Sales Market Share by Application (2017-2028)
Figure 48. North America Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Country (2017-2028)
Figure 49. United States Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Canada Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Mexico Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Europe Peripheral Parenteral Nutrition (PPN) Sales Market Share by Type (2017-2028)
Figure 53. Europe Peripheral Parenteral Nutrition (PPN) Sales Market Share by Application (2017-2028)
Figure 54. Europe Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Country (2017-2028)
Figure 55. Germany Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. France Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. United Kingdom Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Russia Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Italy Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Sales Market Share by Type (2017-2028)
Figure 61. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Sales Market Share by Application (2017-2028)
Figure 62. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Region (2017-2028)
Figure 63. China Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South Korea Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Peripheral Parenteral Nutrition (PPN) Sales Market Share by Type (2017-2028)
Figure 70. South America Peripheral Parenteral Nutrition (PPN) Sales Market Share by Application (2017-2028)
Figure 71. South America Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East and Africa Peripheral Parenteral Nutrition (PPN) Sales Market Share by Type (2017-2028)
Figure 75. Middle East and Africa Peripheral Parenteral Nutrition (PPN) Sales Market Share by Application (2017-2028)
Figure 76. Middle East and Africa Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Country (2017-2028)
Figure 77. Turkey Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. UAE Peripheral Parenteral Nutrition (PPN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
